<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
	<id>http://dustlikestars.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=AudreaBugg72956</id>
	<title>Erkenfara - Benutzerbeiträge [de]</title>
	<link rel="self" type="application/atom+xml" href="http://dustlikestars.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=AudreaBugg72956"/>
	<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=Spezial:Beitr%C3%A4ge/AudreaBugg72956"/>
	<updated>2026-06-17T15:34:13Z</updated>
	<subtitle>Benutzerbeiträge</subtitle>
	<generator>MediaWiki 1.32.2</generator>
	<entry>
		<id>http://dustlikestars.de/index.php?title=5F-ADB_Wikipedia&amp;diff=124293</id>
		<title>5F-ADB Wikipedia</title>
		<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=5F-ADB_Wikipedia&amp;diff=124293"/>
		<updated>2026-06-03T22:01:25Z</updated>

		<summary type="html">&lt;p&gt;AudreaBugg72956: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;In summary, JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability. This commitment to Read the Full Piece of writing quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.&amp;lt;br&amp;gt;Key Features and Specifications to Evaluate &amp;lt;br&amp;gt;In case of cannabis or Δ9-tetrahydrocannabinol, there are many Read the Full Piece of writing previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998). After administering test substances once every other day for 10 days, brain samples of mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and the first trial was performed 2 h after the last administration.&amp;lt;br&amp;gt;How to Choose Powder JWH-210 &amp;lt;br&amp;gt;This dual-use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples like JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based researc&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Morris water maze test was performed to evaluate the changes in learning and memory function. Only a few case reports about the dangers of some synthetic cannabinoids due to neurotoxicity have been published (Cohen et al., 2012; McGuinness et al., 2012; Harris and Brown, 2013; Hermanns et al., 2013). In addition, the lack of information about neurotoxicity of synthetic cannabinoids could allow abusers consume those substances undiscerningly. However, slight structural changes might cause biochemical properties including dependence liability and neurotoxicity. The substances used in the present study both possess naphthoylindole moiety as their parental structure. (B) The ratio of damaged cells containing pyknotic or condensed nuclei and low hematoxilin affinity to total cells were calculated in nucleus accumben&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narro&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans &amp;lt;br&amp;gt;This might be due to the low activity of numerous metabolizing enzymes resulting in lower drug biotransformation . HepG2 model detected the major ester hydrolysis metabolite of 4F-MDMB-BINACA in abundance but the rest of the metabolites were found in a small amount. Elegans and HLM models detected all of the in-vivo metabolites (100%), whilst HepG2 cells detected 7 out of the 8 in-vivo metabolites (87.5%). Hence, structural elucidation could not be confirmed unless a reference standard is made availabl&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo [https://cannabinoidsrc4f-adb.com/ Read the Full Piece of writing] testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) controls. After the last administration, the first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity of a substance is evaluated by animal behavioral aspects, i.e. functional observation battery (FOB) tests (O’Callaghan et al., 2014). Our results suggest that JWH-081 and JWH-210 may Read the Full Piece of writing be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens.&amp;lt;br&amp;gt;About Powder JWH-2&lt;/div&gt;</summary>
		<author><name>AudreaBugg72956</name></author>
		
	</entry>
	<entry>
		<id>http://dustlikestars.de/index.php?title=A_Synthetic_Cannabinoid_JWH-210_Reduces_Lymphoid_Organ_Weights_And_T-cell_Activator_Levels_In_Mice_Via_CB2_Receptors&amp;diff=104440</id>
		<title>A Synthetic Cannabinoid JWH-210 Reduces Lymphoid Organ Weights And T-cell Activator Levels In Mice Via CB2 Receptors</title>
		<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=A_Synthetic_Cannabinoid_JWH-210_Reduces_Lymphoid_Organ_Weights_And_T-cell_Activator_Levels_In_Mice_Via_CB2_Receptors&amp;diff=104440"/>
		<updated>2026-05-28T12:50:52Z</updated>

		<summary type="html">&lt;p&gt;AudreaBugg72956: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;4. Drugs &amp;lt;br&amp;gt;In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.&amp;lt;br&amp;gt;Michael B Gatch &amp;lt;br&amp;gt;Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ 4F ADB] highest dose tested (0.5 mg/kg).&amp;lt;br&amp;gt;Figure 1. &amp;lt;br&amp;gt;There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were 4F ADB observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Such decrease remained 2 hr after the administration (Table 4). In locomotor activity, methamphetamine treated group showed approximately 4.2 times increase compared to the negative control treated group. Change of body weight following the treatments with JWH-081 and JWH-210 in mic&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicit&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity of the mice was measured 30 min and 2 hrs after the last substance administration. We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in the nucleus accumbens core region. In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicity.&amp;lt;br&amp;gt;Table of Conten&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Effects of individual doses were compared to the vehicle control value using a priori contrasts. Response-rate data were analyzed by one-way repeated-measure analysis of variance. Percent drug-appropriate responding was shown only if at 4F ADB least three rats completed the first fixed ratio, whereas all rats are shown for the response rate dat&lt;/div&gt;</summary>
		<author><name>AudreaBugg72956</name></author>
		
	</entry>
	<entry>
		<id>http://dustlikestars.de/index.php?title=Monitoring_Metabolism_Of_Synthetic_Cannabinoid_4F-MDMB-BINACA_Via_High-resolution_Mass_Spectrometry_Assessed_In_Cultured_Hepatoma_Cell_Line,_Fungus,_Liver_Microsomes_And_Confirmed_Using_Urine_Samples_Forensic_Toxicology_Springer_Nature_Link&amp;diff=100431</id>
		<title>Monitoring Metabolism Of Synthetic Cannabinoid 4F-MDMB-BINACA Via High-resolution Mass Spectrometry Assessed In Cultured Hepatoma Cell Line, Fungus, Liver Microsomes And Confirmed Using Urine Samples Forensic Toxicology Springer Nature Link</title>
		<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=Monitoring_Metabolism_Of_Synthetic_Cannabinoid_4F-MDMB-BINACA_Via_High-resolution_Mass_Spectrometry_Assessed_In_Cultured_Hepatoma_Cell_Line,_Fungus,_Liver_Microsomes_And_Confirmed_Using_Urine_Samples_Forensic_Toxicology_Springer_Nature_Link&amp;diff=100431"/>
		<updated>2026-05-25T07:10:44Z</updated>

		<summary type="html">&lt;p&gt;AudreaBugg72956: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The chemical structures of the recent synthetic cannabinoids are unlike that of Δ9-THC, but are largely based on the structure of older synthetic cannabinoids that are known to have substantial abuse liability (Fig. 1&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patient.&amp;lt;br&amp;gt;Data availabili&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .&amp;lt;br&amp;gt;Data availability &amp;lt;br&amp;gt;The intensity is plotted against the retention time for both chromatograms, demonstrating the [https://cannabinoidsrc4f-adb.com/ cannabinoidsrc4f-adb.com] presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Similarly, precursor ion identified at m/z 380 (B19/B21, B23/B25) was 16 Da higher than the 4F-MDMB-BINACA, indicating monohydroxylation at the butyl side chain (B19/B21) and indazole (B23/B25) moieties with product ions m/z 145 and 161, respectively. Metabolites identified at m/z 366 (B8, B9, B13), which was 16 Da higher than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), confirmed monohydroxylation upon ester hydrolysis. Death involving these drugs have been reported [5,6,7,8,9], and this raises public health and social concerns. Due to their similar physiological effects to the principal psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), SCBs are gaining popularity and are often abused as recreational drugs. The fact that similar 4F-MDMB-BINACA and ethanol concentrations were detected in the postmortem blood samples of both victims suggests that both substances played a role in the fatal outcom&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Although there were reports on the metabolism of 4F-MDMB-BINACA using in-vivo and various in-vitro models, studies were either conducted using small in-vivo sample size such as 1 to 4 samples [5, 29] or in closed environments such as forensic psychiatric wards and prisons . The hepatic cell line HepG2 is often used as an initial screen as it is known to produce high reproducibility results with relatively stable enzyme concentration, although they are limited by the low-level expression of several metabolizing enzymes, including the cytochrome P450 (CYP) class of proteins [17, 18]. In-vitro metabolism studies are generally used to complement these data using perfused organs, tissue or cell cultures and microsomal preparations amongst which pooled human liver microsomes (HLM) have been frequently used to elucidate metabolism of SCBs [12,13,14,15,16]. Since most SCBs are found extensively in metabolized forms in urine, the identification of metabolites is of vital importance for forensic and clinical toxicologists. Identifying SCB intake and its correlating specific adverse effects require rapid elucidation of these SCBs. The proliferation of SCBs has become a global challenge as new compounds are rapidly introduced into the illegal drug market to evade existing drug law&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit&lt;/div&gt;</summary>
		<author><name>AudreaBugg72956</name></author>
		
	</entry>
	<entry>
		<id>http://dustlikestars.de/index.php?title=Benutzer:AudreaBugg72956&amp;diff=100430</id>
		<title>Benutzer:AudreaBugg72956</title>
		<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=Benutzer:AudreaBugg72956&amp;diff=100430"/>
		<updated>2026-05-25T07:10:31Z</updated>

		<summary type="html">&lt;p&gt;AudreaBugg72956: Die Seite wurde neu angelegt: „Web Developer II Salmon McFall, hailing from Saint-Sauveur-des-Monts enjoys watching movies like Mystery of the 13th Guest and Digital arts. Took a trip to Gar…“&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Web Developer II Salmon McFall, hailing from Saint-Sauveur-des-Monts enjoys watching movies like Mystery of the 13th Guest and Digital arts. Took a trip to Garden Kingdom of Dessau-Wörlitz and drives a Ferrari 250 GT Series 1 Cabriolet.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Also visit my blog post ... [https://cannabinoidsrc4f-adb.com/ cannabinoidsrc4f-adb.com]&lt;/div&gt;</summary>
		<author><name>AudreaBugg72956</name></author>
		
	</entry>
</feed>